To further investigate whether STING impacts the tumor surveillance of circulating Vγ4 γδ T cells in the lung, we transferred WT and Sting1−/− Vγ4 γδ T cells intravenously (i.v.)on day 1 post‐tumor injection and analyzed the lung tumor burden on day 21. Here, STING1 is linked to neoplasm.